Indications

• Clindamycin is indicated for the treatment of severe infections caused by susceptible Gram-positive aerobic organisms or by susceptible anaerobic organisms.
  
  

Key Benefits

• Clindamycin inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome.
  
  
• It has activity against Gram-positive aerobes and anaerobes as well as the Gram-negative anaerobes.
  
  
• Clindamycin is bacteriostatic